Gen-Probe Inc announced today that it has received a European CE mark for its APTIMA assay for Trichomonas vaginalis, a common parasitic sexually transmitted disease.
Read More
From sample collection to splash protection, safety remains a key concern.
Read MoreWith the market for certain advanced medical testing methods poised for accelerated growth, many diagnostics companies must adjust their portfolios and their business models in order to position themselves for growth.
Read MoreMarketResearch.com has announced the addition of Decision Resources’ new report “How to Enhance the Value of Antiviral Therapies Through Biomarkers and Diagnostics.”
Read MoreAbbott announced that it has received 510(k) clearance from the FDA to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation’s most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia.
Read More